Malignant Melanoma

Showing NaN - NaN of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

Malignant Melanoma Trial in Worldwide (Atezolizumab, Cobimetinib)

Completed
  • Malignant Melanoma
  • Scottsdale, Arizona
  • +42 more
Nov 17, 2021

Malignant Melanoma Trial in Worldwide (Placebo, Vemurafenib, Cobimetinib)

Completed
  • Malignant Melanoma
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +155 more
Sep 14, 2020

Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +7 more
Jul 20, 2020

Malignant Melanoma Trial in United Kingdom, United States (IMCgp100)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jul 1, 2020

Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +9 more
Jul 26, 2019

Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)

Completed
  • Malignant Melanoma
  • Colorectal Carcinoma
  • Los Angeles, California
  • +6 more
Aug 18, 2017

Malignant Melanoma Trial in United States (Drug cocktail, RO5185426)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +4 more
Jul 6, 2017

Malignant Melanoma Trial in Australia, United States (vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +14 more
Jun 26, 2017

Malignant Melanoma Trial in United States (Vemurafenib)

Terminated
  • Malignant Melanoma
  • Tucson, Arizona
  • +14 more
Apr 24, 2017

Malignant Melanoma Trial in Canada, United States (Nivolumab, Ipilimumab)

No longer available
  • Malignant Melanoma
  • Gilbert, Arizona
  • +65 more
Feb 6, 2017

Malignant Melanoma Trial in Australia, United States (DEDN6526A)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +5 more
Nov 1, 2016

Malignant Melanoma Trial in United States (RO5185426)

Completed
  • Malignant Melanoma
  • La Jolla, California
  • +9 more
Nov 1, 2016

Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)

Completed
  • Malignant Melanoma
  • Birmingham, Alabama
  • +110 more
Aug 19, 2016

Malignant Melanoma Trial in United States (RO5185426)

Completed
  • Malignant Melanoma
  • Tucson, Arizona
  • +27 more
Jul 12, 2016

Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

Completed
  • Melanoma
  • Malignant Melanoma
  • New Haven, Connecticut
  • +17 more
Dec 16, 2015

Malignant Melanoma Trial in United States (CP-675,206)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jun 5, 2012

Melanoma, Malignant Melanoma Trial in Nashville (lovastatin, interferon alfa-2b)

Withdrawn
  • Melanoma
  • Malignant Melanoma
  • Nashville, Tennessee
    NeoPlas Innovation
Sep 4, 2009

Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

Unknown status
  • Malignant Melanoma
  • CancerVax vaccine (CANVAXIN)
  • Tucson, Arizona
  • +79 more
Jun 23, 2005

Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

Unknown status
  • Malignant Melanoma
  • CancerVax vaccine (CANVAXIN)
  • Tucson, Arizona
  • +76 more
Jun 23, 2005